Politician trade (Senate)

Axon Enterprise (AXON)Sen. Alan Armstrong disclosed a purchase $1K–$15K

Sen. Alan Armstrong disclosed a purchase of Axon Enterprise in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
116 days
Disclosure lag
Traded
Mar 27, 2026
Disclosed
Jul 21, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Feb 17, 2026Court · District Court, District of ColumbiaSecurities lawsuit filed: NATHAN CUMMINGS FOUNDATION, INC. v. AXON ENTERPRISE, INC.
  2. Feb 24, 2026Company filing · Form 8-K · ResultsReported its results
  3. Feb 25, 2026InsiderCEO sold ~$5M of AXON shares in the open market
  4. Feb 27, 2026Insider · 2 peopleInsiders: 3 sales (~$1.6M)
  5. Mar 2, 2026Insider · 2 peopleInsiders: 7 sales (~$3.2M)
  6. Mar 5, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 5, 2026, Julie Anne Cullivan notified the Board of Directors (the “Board”) of Axon Enterprise, Inc. (the “Company”) that she will not stand for re-election as a director at the Company’s 2026 Annual Meeting of Shareholders (the “Annual Meeting”).”
  7. Mar 9, 2026Insider · 2 peopleInsiders: 25 sales (~$6.3M)
  8. Mar 10, 2026Insider · 1 personInsiders: 18 sales (~$18.5M)
  9. Mar 17, 2026Insider · 2 peopleInsiders: 2 sales (~$177K)
  10. Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)

What came next

  1. Apr 6, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On April 6, 2026, Matthew McBrady notified the Board of Directors (the “Board”) of Axon Enterprise, Inc. (the “Company”) that he will not stand for re-election as a director at the Company’s 2026 Annual Meeting of Shareholders (the “Annual Meeting”).”
  2. Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.2%
  3. May 6, 2026Company filing · Form 8-K · ResultsReported its results
  4. May 22, 2026InsiderOfficer sold ~$800K of AXON shares in the open market
  5. Jun 1, 2026Insider · 2 peopleInsiders: 10 sales (~$566K)
  6. Jun 2, 2026Insider · Their largest sale since 2023CFO sold ~$2.89M of AXON shares in the open market
  7. Jun 5, 2026Insider · 1 personInsiders: 12 sales (~$5.5M)
  8. Jul 8, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On July 8, 2026, Vivek Mohindra and Eiso Kant were appointed to the Board of Directors (the “Board”) of Axon Enterprise, Inc. (the “Company”) effective immediately.”
View the official recordSenate eFD periodic transaction report

How to read Senate eFD periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Axon Enterprise

For Axon Enterprise, OQRO holds 97 insider filings (SEC Form 4 or Form 144), 1 Congress trade report, 16 fund holdings reports (13F) and 8 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AXON page.

Other recent filings by Sen. Alan Armstrong

The full history of Sen. Alan Armstrong is on the profile page.

How this filing works

Other disclosures at Axon Enterprise

Everything OQRO holds on this company is on its AXON page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data